Institut de Recherche en Sciences de la Santé, BP 545, Bobo Dioulasso, Burkina Faso.
Department of Life Sciences, Imperial College London, London, UK.
Malar J. 2021 Oct 9;20(1):395. doi: 10.1186/s12936-021-03929-2.
Innovative tools are needed to complement the existing approach for malaria elimination. Gene drive mosquitoes are one potential new technology in the control of malaria vectors. Target Malaria is one of the research projects developing this technology, and in July 2019, the project proceeded to an important step for this evaluation pathway: the small-scale release of non-gene drive sterile male mosquitoes in a village in Burkina Faso. In addition to the entomological and laboratory work to prepare for this important milestone, significant community and stakeholder engagement work was done. The existing guidelines on gene drive mosquito provide an overall framework for such engagement work. However, they do not provide a road map on how to proceed or what benchmarks should be used to assess this work.
This study provides a review of engagement activities relevant to field trials on non-gene drive genetically-modified mosquitoes as well as an assessment framework-using both qualitative and quantitative studies as well as an audit procedure. The latter was implemented to evaluate whether the release activities could proceed with the appropriate level of agreement from the community.
This paper shows the importance of this first phase of work to innovate and learn about engagement processes for responsible research in the field of genetic approaches for malaria vector control. The function of these assessments is crucial for the learning agenda. The assessments demonstrated ways to increase understanding and ensure effective progress with field studies and, therefore, the pathway for responsible research.
Gene drive technology is increasingly considered as a promising approach to control vector borne diseases, in particular malaria. Stakeholders' involvement in this research process is one of the recurring requirements in international guidance documents. With this paper Target Malaria offers an opportunity to explore the practical achievements and challenges of stakeholder engagement during early phases of a technology evaluation, and in particular how it implemented an assessment framework to learn from its experience.
需要创新工具来补充现有的消除疟疾方法。基因驱动蚊子是控制疟疾媒介的一种潜在新技术。Target Malaria 是开发这项技术的研究项目之一,2019 年 7 月,该项目朝着评估途径的一个重要步骤迈进:在布基纳法索的一个村庄小规模释放非基因驱动不育雄蚊。除了为这一重要里程碑进行的昆虫学和实验室工作外,还开展了大量的社区和利益攸关方参与工作。现有的基因驱动蚊子准则为这类参与工作提供了总体框架,但没有提供如何进行的路线图或应使用哪些基准来评估这项工作。
本研究审查了与非基因驱动遗传修饰蚊子田间试验相关的参与活动,以及评估框架——使用定性和定量研究以及审计程序。后者是为了评估释放活动是否可以在社区的适当同意水平下进行。
本文表明,在遗传方法控制疟疾媒介领域的负责任研究中,创新和了解参与过程的这一第一阶段工作非常重要。这些评估的功能对于学习议程至关重要。评估展示了如何增加理解并确保田间研究取得有效进展,从而为负责任的研究开辟道路。
基因驱动技术越来越被认为是控制媒介传播疾病,特别是疟疾的一种有前途的方法。利益攸关方参与这一研究过程是国际指导文件中反复提出的要求之一。本文 Target Malaria 提供了一个机会,探索技术评估早期阶段利益攸关方参与的实际成果和挑战,特别是它如何实施评估框架以从经验中学习。